Reducing time spent sitting and increasing light physical activity has important health benefits that may reduce the risk of diabetes and other cardiovascular diseases.
Weight Loss :: Glaxo’s alli, OTC weight loss product on shelves in US
GlaxoSmithKline Consumer Healthcare [NYSE: GSK] announces that alli?, the only FDA-approved over-the-counter weight loss product will be on shelves of pharmacies, grocery stores and mass merchandisers nationwide later this week.